Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BowTiedBiotech Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1462941795520638981.png) BowTiedBiotech 🧪🔬🧬 [@BowTiedBiotech](/creator/twitter/BowTiedBiotech) on x 19.6K followers
Created: 2025-05-15 11:22:10 UTC

Top XX Pharma M&A Projections Brought To You By Grok

Top XX Takeover Predictions:

1️⃣ Viking Therapeutics ( $VKTX, $5B, GLP-1)
VK2735 could appeal to $LLY

2️⃣ Structure Therapeutics ( $GPCR, $2B, GLP-1)
Oral GSBR-1290 fits $PFE needs

3️⃣ Hanmi Science ( KOSDAQ:128940, $3B, GLP-1)
Strong IP, could attract $SNY

4️⃣ Zealand Pharma ( CPH:ZEAL, $4B, GLP-1)
Innovative pipeline, suits $GSK

5️⃣ BioAtla ( $BCAB, $1.5B, immuno-oncology)
Target diversity, fits $MRK model

6️⃣ ImCyse (Private, $1B, immunology)
Precision immunology, right for $RHHBY

7️⃣ Rubius Therapeutics (Private, $2B, radiopharma)
Early but intriguing, could suit $AMGN

8️⃣ Vectus Biosystems ( ASX:VBS, $0.5B, GLP-1)
Small but relevant for $NVO

9️⃣ Orgenesis ( $ORGS, $1B, cell therapy)
Scalable model, fits $AZN’s strategy

🔟 Ambrx Biopharma ( $AMAM, $2B, radiopharma)
Oncology focus fits $JNJ

![](https://pbs.twimg.com/media/Gq_AtPzWMAAlDzD.jpg)

XXXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1922975790993440911/c:line.svg)

**Related Topics**
[drugs](/topic/drugs)
[surge](/topic/surge)
[$gsk](/topic/$gsk)
[$4b](/topic/$4b)
[$zealco](/topic/$zealco)
[$sny](/topic/$sny)
[$3b](/topic/$3b)
[$008930ks](/topic/$008930ks)

[Post Link](https://x.com/BowTiedBiotech/status/1922975790993440911)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BowTiedBiotech Avatar BowTiedBiotech 🧪🔬🧬 @BowTiedBiotech on x 19.6K followers Created: 2025-05-15 11:22:10 UTC

Top XX Pharma M&A Projections Brought To You By Grok

Top XX Takeover Predictions:

1️⃣ Viking Therapeutics ( $VKTX, $5B, GLP-1) VK2735 could appeal to $LLY

2️⃣ Structure Therapeutics ( $GPCR, $2B, GLP-1) Oral GSBR-1290 fits $PFE needs

3️⃣ Hanmi Science ( KOSDAQ:128940, $3B, GLP-1) Strong IP, could attract $SNY

4️⃣ Zealand Pharma ( CPH:ZEAL, $4B, GLP-1) Innovative pipeline, suits $GSK

5️⃣ BioAtla ( $BCAB, $1.5B, immuno-oncology) Target diversity, fits $MRK model

6️⃣ ImCyse (Private, $1B, immunology) Precision immunology, right for $RHHBY

7️⃣ Rubius Therapeutics (Private, $2B, radiopharma) Early but intriguing, could suit $AMGN

8️⃣ Vectus Biosystems ( ASX:VBS, $0.5B, GLP-1) Small but relevant for $NVO

9️⃣ Orgenesis ( $ORGS, $1B, cell therapy) Scalable model, fits $AZN’s strategy

🔟 Ambrx Biopharma ( $AMAM, $2B, radiopharma) Oncology focus fits $JNJ

XXXXXX engagements

Engagements Line Chart

Related Topics drugs surge $gsk $4b $zealco $sny $3b $008930ks

Post Link

post/tweet::1922975790993440911
/post/tweet::1922975790993440911